![logo](/logos/EVFM.webp)
Evofem Biosciences, Inc.
OTC:EVFM
0.06 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Evofem Biosciences, Inc. |
Symbool | EVFM |
Munteenheid | USD |
Prijs | 0.07 |
Beurswaarde | 15,117,269 |
Dividendpercentage | 0% |
52-weken bereik | 0.055 - 11.875 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Saundra Pelletier |
Website | https://www.evofem.com |
An error occurred while fetching data.
Over Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)